Success Metrics

Clinical Success Rate
84.6%

Based on 11 completed trials

Completion Rate
85%(11/13)
Active Trials
0(0%)
Results Posted
18%(2 trials)
Terminated
2(14%)

Phase Distribution

Ph not_applicable
8
57%
Ph phase_1
1
7%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(11)
Terminated(2)
Other(1)

Detailed Status

Completed11
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
84.6%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (11.1%)
N/A8 (88.9%)

Trials by Status

terminated214%
unknown17%
completed1179%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
OTHER
Total Trials
14